{"transactions":[{"id":4617837,"issuer":{"id":5259,"kind":"organization","name":"AgomAb Therapeutics NV","symbol":"AGMB"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T20:06:59.000Z","date":"2026-09-11","kind":"grant","planned":false,"acquired":true,"shares":57482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The common shares may be represented by American Depositary Shares, each of which currently represents one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The exercise price is reported in U.S. dollars and reflects the conversion from EUR to USD at an exchange rate of $1.1616 per EUR 1.00 as of September 10, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"33% of the shares underlying this option shall vest on September 11, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":57482,"derivative":{"exercise_price":13.94,"expiration_date":"2036-01-15","underlying":"Common shares","underlying_shares":57482},"source":{"system":"sec-edgar","filing":"0001104659-26-107916","document":"tm2625420-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2020932/000110465926107916/tm2625420-4_4seq1.xml","form_type":"4"}},{"id":693076,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"exercise","planned":true,"acquired":false,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":160004,"derivative":{"exercise_price":8.44,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":126000},"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693075,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":286004,"derivative":{"exercise_price":8.44,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693074,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":21909,"price":108.72,"value":2381946.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.57 to $108.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":65292,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693073,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":104091,"price":107.96,"value":11237664.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.52 to $108.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":87102,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693072,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":800,"price":110.76,"value":88608.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026."}],"balance_after":191292,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693071,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":2536,"price":110.02,"value":279010.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.75 to $110.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":192092,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693070,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":2373,"price":109.1,"value":258894.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.74 to $109.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":194628,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693069,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":23907,"price":108.05,"value":2583151.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.68 to $108.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":197001,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693068,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":10384,"price":107.49,"value":1116176.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.68 to $107.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":220908,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693067,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"exercise","planned":true,"acquired":true,"shares":126000,"price":8.44,"value":1063440.0,"ownership":{"direct":true},"balance_after":231292,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":693066,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-08-07T22:30:37.000Z","date":"2026-08-07","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":8.44,"value":337600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026."}],"balance_after":105292,"source":{"system":"sec-edgar","filing":"0001669866-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000010/ownership.xml","form_type":"4"}},{"id":837989,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:22:50.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":false,"shares":5592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":269408,"derivative":{"exercise_price":17.88,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":5592},"source":{"system":"sec-edgar","filing":"0001669866-26-000007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000007/ownership.xml","form_type":"4"}},{"id":837988,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:22:50.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":false,"shares":59700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vested in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":41,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":59700},"source":{"system":"sec-edgar","filing":"0001669866-26-000007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000007/ownership.xml","form_type":"4"}},{"id":837987,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-03-17T21:22:50.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":5592,"price":17.88,"value":99984.96,"ownership":{"direct":true},"balance_after":65292,"source":{"system":"sec-edgar","filing":"0001669866-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000007/ownership.xml","form_type":"4"}},{"id":837986,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-03-17T21:22:50.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":59700,"price":6.7,"value":399990.0,"ownership":{"direct":true},"balance_after":59700,"source":{"system":"sec-edgar","filing":"0001669866-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000007/ownership.xml","form_type":"4"}},{"id":843917,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-14T00:30:07.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":false,"shares":122918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vested in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":59741,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":122918},"source":{"system":"sec-edgar","filing":"0001669866-26-000005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000005/ownership.xml","form_type":"4"}},{"id":843916,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:07.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":900,"price":85.53,"value":76977.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001669866-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000005/ownership.xml","form_type":"4"}},{"id":843915,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:07.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":200,"price":83.38,"value":16676.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2025."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0001669866-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000005/ownership.xml","form_type":"4"}},{"id":843914,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:07.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":12796,"price":82.6,"value":1056949.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.29 to $83.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1100,"source":{"system":"sec-edgar","filing":"0001669866-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000005/ownership.xml","form_type":"4"}},{"id":843913,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:07.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":65517,"price":81.74,"value":5355359.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.29 to $82.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":13896,"source":{"system":"sec-edgar","filing":"0001669866-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000005/ownership.xml","form_type":"4"}},{"id":843912,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:07.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":43505,"price":80.69,"value":3510418.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.29 to $81.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":79413,"source":{"system":"sec-edgar","filing":"0001669866-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000005/ownership.xml","form_type":"4"}},{"id":843911,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:07.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":true,"shares":122918,"price":6.7,"value":823550.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2025."}],"balance_after":122918,"source":{"system":"sec-edgar","filing":"0001669866-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000005/ownership.xml","form_type":"4"}},{"id":919417,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T22:39:16.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":355000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2026, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":355000,"derivative":{"exercise_price":52.46,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":355000},"source":{"system":"sec-edgar","filing":"0001669866-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986626000002/ownership.xml","form_type":"4"}},{"id":1024606,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T23:00:04.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after September 30, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":39.35,"expiration_date":"2035-09-30","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001669866-25-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000166986625000004/ownership.xml","form_type":"4"}},{"id":1284867,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:13:16.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":340000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":340000,"derivative":{"exercise_price":22.07,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":340000},"source":{"system":"sec-edgar","filing":"0000950170-25-013443","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017025013443/ownership.xml","form_type":"4"}},{"id":1500439,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T00:03:22.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":243000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":243000,"derivative":{"exercise_price":21.77,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":243000},"source":{"system":"sec-edgar","filing":"0000950170-24-065562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024065562/ownership.xml","form_type":"4"}},{"id":1669541,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO AND PRESIDENT"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T21:36:38.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":275000,"derivative":{"exercise_price":17.88,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000950170-24-007979","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024007979/ownership.xml","form_type":"4"}},{"id":4103109,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":25437,"kind":"person","name":"Garcia Marino","position":1,"cik":"0001669866","reported_name":"Garcia Marino","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Strategy Officer"}}],"security":"Stock Options","published_at":"2018-01-09T22:01:20.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"93,333 of the stock options vest on 1/5/2019 and 2020 and 93,334 vest on 1/5/2021."}],"balance_after":1010000,"derivative":{"exercise_price":2.18,"expiration_date":"2028-01-05","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001104659-18-001492","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669866/000110465918001492/a4.xml","form_type":"4"}}]}